Pennant Investors »

Seres Therapeutics shares owned by Pennant Investors

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Pennant Investors from 13F filings

Historical chart of Pennant Investors investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Pennant Investors

Quarter filed Position value Share count Share price at filing
2024-06-30 $212k 292k 0.72
2024-03-31 $226k 292k 0.77

More positions owned by Pennant Investors

Echostar Corp Cl A (SATS)
Antero Res (AR)
Perimeter Solutions Sa Common Stock (PRM)
Micron Technology (MU)
Amazon (AMZN)
TransDigm Group Incorporated (TDG)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Vertiv Holdings Com Cl A (VRT)
Ge Vernova (GEV)
Valmont Industries (VMI)
Core Scientific (CORZ)
Iris Energy Ordinary Shares (IREN)
Asml Holding N V N Y Registry Shs (ASML)
Grab Holdings *w Exp 99/99/999 (GRABW)

View all positions for Pennant Investors

Top funds holding Seres Therapeutics

Flagship Ventures Management
FMR
Vanguard Group
BlackRock
Susquehanna International
Geode Capital Management
Millennium Management
Charles Schwab Investment Management
Schonfeld Strategic Advisors
Vontobel Holding
State Street Corporation
Lion Point Capital
Citadel Advisors
Cantor Fitzgerald, L. P.
Bridgeway Capital Management

View all funds holding Seres Therapeutics